Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
62.00
-0.95 (-1.51%)
May 28, 2026, 9:59 AM HKT

Nanjing Leads Biolabs Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Nanjing Leads Biolabs stock has a consensus rating of "Buy" and an average price target of $94.77. The average 1-year stock price forecast is 52.85% higher than the current stock price, while the lowest is $59.10 (-4.68%) and the highest is $109.36 (+76.39%).

Price Target: $94.77 (+52.85%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$59.10$94.77$105.31$109.36
Change-4.68%+52.85%+69.85%+76.39%
* Price targets were last updated on Apr 28, 2026.

Analyst Ratings

The average analyst rating for Nanjing Leads Biolabs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Mar '26Apr '26May '26
Strong Buy122222
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total344444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
GF Securities
No rating
GF Securities
Buy
Maintains
$110.96
BuyMaintains$110.96+78.97%Apr 28, 2026
Unknown Analyst
Orient Securities
No rating
Orient Securities
Buy
Maintains
$81.01$103.06
BuyMaintains$81.01$103.06+66.23%Apr 21, 2026
Unknown Analyst
Huafu Securities
No rating
Huafu Securities
Buy
Maintains
$101.90$140.75
BuyMaintains$101.90$140.75+127.02%Apr 15, 2026
Andy Wang
CMB International Securities
No rating
CMB International Securities
Buy
Maintains
$100.50
BuyMaintains$100.50+62.10%Mar 31, 2026
Unknown Analyst
CLSA
No rating
CLSA
Buy
Maintains
$108.00
BuyMaintains$108.00+74.19%Mar 30, 2026
More Analyst Ratings
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.